Dr. Olivier Richoz has been a resident in ophthalmology at the Geneva University Hospitals, Switzerland, where he completed his MD-PhD on the topic of corneal collagen crosslinking with respect to physiology and optimization of keratoconus treatment, as well as application to infectious keratitis and progressive myopia. He published articles on the oxygen dependency of collagen crosslinking and the effect of high fluency on the bacterial killing rate of collagen crosslinking. He is the coauthor of 23 peer-reviewed publications and 3 patents. He is the recipient of a fellowship grant from the Swiss National Fund and the Swiss Commission for Technology and Innovation. He is currently in a corneal-anterior segment fellowship at the Royal Victoria Hospital, UK.
